NASDAQ:TECH

Bio-techne Stock Insider Trading

Healthcare > Biotechnology

Buy TECH

*Your capital is at risk

$50.85

+1.08 (+2.17%)

At Close: Jun 03, 2026

Bio-Techne Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be positive at 30.84. In total, the insiders bought 1M and sold 279.65K TECH shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power (Last 100 transactions)	30.84
● Buy	1M shares
● Sell	279.65K shares
78% Buy Activity Weak Positive Correlation
Buy Signal Medium Confidence Mar 02, 2026 Analysis Breakdown: Supported by a positive Insider Power Score of 30.84. Confidence increased due to high data reliability score of 100. Supported by overwhelming buy-side pressure (78% buys).

Historical Insider Trades

Date	Type	Person	Role	Amount
Nov 03, 2025 Sell	Common Stock F-InKind	Hippel James CFO	C-Suite Officer	11 865 Value: $742.4K
Nov 03, 2025 Buy	Restricted Stock Units M-Exempt	Hippel James CFO	C-Suite Officer	11 545 Value: $707.2K
Nov 03, 2025 Buy	Restricted Stock Units M-Exempt	Geist William President, Protein Sciences	CEO / President	9 911 Value: $607.1K
Nov 03, 2025 Buy	Restricted Stock Units M-Exempt	Hippel James CFO	C-Suite Officer	13 159 Value: $806.1K
Nov 03, 2025 Buy	Common Stock M-Exempt	Geist William President, Protein Sciences	CEO / President	9 911 Value: $607.1K
Nov 03, 2025 Sell	Common Stock F-InKind	Geist William President, Protein Sciences	CEO / President	4 520 Value: $282.8K
Oct 30, 2025 Buy	Common Stock A-Award	Vessey Rupert Director	Director	1 640 Value: $100.0K
Oct 30, 2025 Buy	Stock Option (Right to Buy) A-Award	Klimovsky Judith V. Director	Director	3 777 Value: $230.2K
Oct 30, 2025 Buy	Stock Options (Right to Buy) A-Award	Seth Alpna Director	Director	3 777 Value: $230.2K
Oct 30, 2025 Buy	Common Stock A-Award	Seth Alpna Director	Director	1 640 Value: $100.0K
Oct 30, 2025 Buy	Stock Options (Right to Buy) A-Award	Higgins John L Director	Director	3 777 Value: $230.2K
Oct 30, 2025 Buy	Stock Options (Right to Buy) A-Award	Bushman Julie L Director	Director	3 777 Value: $230.2K
Oct 30, 2025 Buy	Common Stock A-Award	Bushman Julie L Director	Director	1 640 Value: $100.0K
Oct 30, 2025 Buy	Common Stock A-Award	Keegan Joseph D Director	Director	1 640 Value: $100.0K
Oct 30, 2025 Buy	Stock Options (Right to Buy) A-Award	Keegan Joseph D Director	Director	3 777 Value: $230.2K
Oct 30, 2025 Buy	Common Stock A-Award	Higgins John L Director	Director	1 640 Value: $100.0K
Oct 30, 2025 Buy	Stock Option (Right to Buy) A-Award	Herr Amy E. Director	Director	3 777 Value: $230.2K
Oct 30, 2025 Buy	Common Stock A-Award	Herr Amy E. Director	Director	1 640 Value: $100.0K
Oct 30, 2025 Buy	Common Stock A-Award	Klimovsky Judith V. Director	Director	1 640 Value: $100.0K
Oct 30, 2025 Buy	Stock Options (Right to Buy) A-Award	Vessey Rupert Director	Director	3 777 Value: $230.2K
Oct 30, 2025 Buy	Common Stock A-Award	Baumgartner Robert V Director	Director	1 640 Value: $100.0K
Oct 30, 2025 Buy	Stock Options (Right to Buy) A-Award	Baumgartner Robert V Director	Director	3 777 Value: $230.2K
Aug 25, 2025 Buy	Common Stock M-Exempt	Nusse Roeland Director	Director	17 040 Value: $372.2K
Aug 25, 2025 Sell	Common Stock S-Sale	Nusse Roeland Director	Director	17 040 Value: $960.4K
Aug 25, 2025 Buy	Stock Options (Right to Buy) M-Exempt	Nusse Roeland Director	Director	17 040 Value: $372.2K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%^* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

ABOUT BIO-TECHNE CORP

Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research, and diagnostics and bioprocessing markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment provides biological reagents used in various aspects of life science research, diagnostics, and cell and gene therapy, s...

Read Full Profile Here